Tuberous Sclerosis Clinical Trials

11 recruiting

Tuberous Sclerosis Trials at a Glance

19 actively recruiting trials for tuberous sclerosis are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Phase 2 with 4 trials, with the heaviest enrollment activity in Warsaw, Chicago, and Cincinnati. Lead sponsors running tuberous sclerosis studies include National Heart, Lung, and Blood Institute (NHLBI), Katarzyna Kotulska, and GRIN Therapeutics, Inc..

Browse tuberous sclerosis trials by phase

Treatments under study

About Tuberous Sclerosis Clinical Trials

Looking for clinical trials for Tuberous Sclerosis? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Tuberous Sclerosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Tuberous Sclerosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 119 of 19 trials

Recruiting

Study of Skin Tumors in Tuberous Sclerosis

Tuberous Sclerosis
National Heart, Lung, and Blood Institute (NHLBI)400 enrolled1 locationNCT00001975
Recruiting

Role of Genetic Factors in the Development of Lung Disease

AsthmaCystic FibrosisPulmonary Fibrosis+2 more
National Heart, Lung, and Blood Institute (NHLBI)3,500 enrolled2 locationsNCT00001532
Recruiting

Study of the Disease Process of Lymphangioleiomyomatosis

PneumothoraxLymphangioleiomyomatosisLung Disease+1 more
National Heart, Lung, and Blood Institute (NHLBI)2,000 enrolled1 locationNCT00001465
Recruiting

Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY

Dravet SyndromeTuberous Sclerosis ComplexLennox Gastaut Syndrome
Jazz Pharmaceuticals100 enrolled18 locationsNCT05485831
Recruiting
Phase 3

Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC)

Tuberous Sclerosis Complex (TSC)
Oils4Cure84 enrolled1 locationNCT07403266
Recruiting

Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)

LymphangioleiomyomatosisTuberous Sclerosis Complex
David M. Ritter300 enrolled1 locationNCT06160310
Recruiting
Not Applicable

Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)

Tuberous SclerosisFragile X SyndromeRett Syndrome+5 more
Rush University Medical Center92 enrolled1 locationNCT06139172
Recruiting
Phase 2

Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study

EpilepsyTuberous Sclerosis Complex
Darcy Krueger64 enrolled11 locationsNCT05104983
Recruiting
Phase 1

Sapu003 in Advanced mTOR-sensitive Solid Tumors

Breast Cancer MetastaticNeuroendocrine TumorsRenal Cell Carcinoma (RCC)+2 more
SAPU NANO (US) LLC27 enrolled1 locationNCT07369505
Recruiting
Phase 2

Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders

AnxietyTuberous SclerosisFragile X Syndrome+14 more
Holland Bloorview Kids Rehabilitation Hospital130 enrolled8 locationsNCT06081348
Recruiting

TSC Biosample Repository and Natural History Database

LymphangioleiomyomatosisTuberous Sclerosis
National Tuberous Sclerosis Association5,000 enrolled24 locationsNCT05676099
Recruiting
Phase 1Phase 2

Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II

Tuberous Sclerosis ComplexFocal Cortical Dysplasia
GRIN Therapeutics, Inc.30 enrolled20 locationsNCT06392009
Recruiting

Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling

Quality of LifeTuberous SclerosisBirt-Hogg-Dube Syndrome+7 more
Maastricht University Medical Center25 enrolled1 locationNCT06330350
Recruiting

Observational, Retrospective, Multicenter, Nonprofit Study on the Prevalence of Renal Involvement in Pediatric Patients With Tuberous Sclerosis

Tuberous Sclerosis Complex (TSC)
IRCCS Azienda Ospedaliero-Universitaria di Bologna80 enrolled1 locationNCT06764602
Recruiting

Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

Neuroendocrine NeoplasmParagangliomaPheochromocytoma+23 more
Universidad Nacional Autonoma de Mexico750 enrolled3 locationsNCT06523582
Recruiting
Phase 2Phase 3

Efficacy and Safety of Rapamycin Versus Vigabatrin in the Prevention of Tuberous Sclerosis Complex Symptoms in Infants

Tuberous Sclerosis Complex
Katarzyna Kotulska60 enrolled2 locationsNCT04987463
Recruiting

National Registry of Rare Kidney Diseases

Denys-Drash SyndromeTuberous SclerosisAutosomal Recessive Polycystic Kidney Disease+81 more
UK Kidney Association35,000 enrolled1 locationNCT06065852
Recruiting

GROWing Up With Rare GENEtic Syndromes

Congenital Adrenal HyperplasiaPrader-Willi SyndromeTuberous Sclerosis+12 more
dr. Laura C. G. de Graaff-Herder600 enrolled1 locationNCT04463316
Recruiting
Phase 3

Placebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With Tuberous Sclerosis Complex

Tuberous Sclerosis Complex
Katarzyna Kotulska200 enrolled2 locationsNCT05534672